Heron Therapeutics Inc vs US Bancorp — how do they compare? Heron Therapeutics Inc trades at $0.48 (market cap $91.46M), while US Bancorp trades at $63.47 (market cap $98.36B). The key difference: US Bancorp is far larger — about 1075.4× Heron Therapeutics Inc's market cap, and US Bancorp pays a 3.29% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | USB | |
|---|---|---|
Market Cap | $91.46M | $98.36B |
Sector | Health | Financials |
52-Week High | $1.96 | $64.01 |
52-Week Low | $0.39 | $43.94 |
Enterprise Value | $189.36M | — |
Dividend Yield | — | 3.29% |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.4804, up 2.06% today, with a bullish technical signal despite mixed earnings. The stock shows a low price-to-sales ratio of 0.51 but negative profitability, with a net income margin of -20.53% in 2026. Recent Q1 2026 earnings missed expectations, though management reaffirmed full-year guidance. Analyst consensus is strongly bullish with 94.7% buy ratings.
Outlook remains speculative given persistent losses and cash burn, but potential upside exists if operational improvements materialize. Key risks include patent litigation outcomes and reliance on revenue growth to achieve profitability. Investors should weigh high analyst optimism against fundamental challenges.
No Aura AI signal available yet.
Trailing returns across standard periods
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →As a diversified financial-services provider, U.S. Bancorp is one of the nation's largest regional banks, with branches in well over 20 states, primarily in the Western and Midwestern United States. The bank offers many services, including retail banking, commercial banking, trust and wealth services, credit cards, mortgages, and other payments capabilities.
Read more on USB →